Literature DB >> 27367595

Benign prostatic hyperplasia: A clinical review.

Danielle Skinder1, Ilana Zacharia, Jillian Studin, Jean Covino.   

Abstract

Benign prostatic hyperplasia (BPH) is an increasingly common diagnosis seen in men over age 50 years. Primary care providers must be aware of patient presentation, diagnostic tests, appropriate lifestyle modifications, treatment options, and potential complications in order to properly manage and educate patients with BPH. If left untreated, BPH can significantly decrease a man's quality of life; however, many pharmacologic and surgical treatments are available to control the symptoms.

Entities:  

Mesh:

Year:  2016        PMID: 27367595     DOI: 10.1097/01.JAA.0000488689.58176.0a

Source DB:  PubMed          Journal:  JAAPA        ISSN: 0893-7400


  7 in total

1.  A Dual-Frequency Colinear Array for Acoustic Angiography in Prostate Cancer Evaluation.

Authors:  Sibo Li; Jinwook Kim; Zhuochen Wang; Sandeep Kasoji; Brooks D Lindsey; Paul A Dayton; Xiaoning Jiang
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2018-10-01       Impact factor: 2.725

2.  The effectiveness of electrical stimulation for the management of benign prostatic hyperplasia: A protocol for systematic review and meta analysis.

Authors:  Wei-Jun Han; Yu-Ge Guo; Yun-Qi Wang; Jin-Wan Wang
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

3.  Development and optimization of a tamsulosin nanostructured lipid carrier loaded with saw palmetto oil and pumpkin seed oil for treatment of benign prostatic hyperplasia.

Authors:  Rana B Bakhaidar; Khaled M Hosny; Imman M Mahier; Waleed Y Rizq; Awaji Y Safhi; Deena M Bukhary; Muhammad H Sultan; Haitham A Bukhary; Osama A Madkhali; Fahad Y Sabei
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

4.  Effect of Beclin-1 gene silencing on autophagy and apoptosis of the prostatic hyperplasia epithelial cells.

Authors:  Rongfu Liu; Song Zhang; Rui Wan; Jiang Deng; Wei Fang
Journal:  Clinics (Sao Paulo)       Date:  2022-09-08       Impact factor: 2.898

5.  Retrospective analysis of the changes in the surgical treatment of benign prostatic hyperplasia during an 11-year period: a single-center experience.

Authors:  Zhu-Feng Peng; Jing Zhou; Pan Song; Lu-Chen Yang; Bo Yang; Zheng-Ju Ren; Lin-Chun Wang; Qiang Wei; Qiang Dong
Journal:  Asian J Androl       Date:  2021 May-Jun       Impact factor: 3.285

6.  Outcomes of prostate artery embolisation for benign prostatic hyperplasia in 10 cases at Steve Biko Academic Hospital.

Authors:  Hatty G Fischer; Farhana E Suleman; Samia Ahmad
Journal:  SA J Radiol       Date:  2019-02-11

7.  Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes.

Authors:  Deli Liu; Jonathan E Shoag; Daniel Poliak; Ramy S Goueli; Vaishali Ravikumar; David Redmond; Aram Vosoughi; Jacqueline Fontugne; Heng Pan; Daniel Lee; Domonique Thomas; Keyan Salari; Zongwei Wang; Alessandro Romanel; Alexis Te; Richard Lee; Bilal Chughtai; Aria F Olumi; Juan Miguel Mosquera; Francesca Demichelis; Olivier Elemento; Mark A Rubin; Andrea Sboner; Christopher E Barbieri
Journal:  Nat Commun       Date:  2020-04-24       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.